Interestingly, there was also WNT pathway involvement through LOH of Dsh (Dishevelled), PLD2, MEK4, and CRK; mapping to canonical WNT signaling in colorectal cancer, hepatocellular cancer, and lung cancer; frequently in the same maps associated with p53. This evidence concerns the gene PLD2 and lung cancer.